Mounjaro, the First and Only GIP and GLP-1 Receptor Agonist Approved for Type 2 Diabetes.
Business
The findings support the increasing amount of data showing that N6LS is a strong antiviral that may be used as part of an all-encompassing antiretroviral treatment plan.
GUB014295 is a calcitonin and amylin receptor-specific agonist that may be a long-acting amylin analog.
The European Commission is currently taking final action on the application for the use of Jaypirca in patients with relapsed or refractory CLL who have received prior treatment with a BTK inhibitor as a result of this favorable view.
American pharma giant Merck’s application for KEYTRUDA® (pembrolizumab) receives US FDA’s priority review acceptance. Acceptance based on results from the KEYNOTE-689 trial. This is the first Phase 3 study to show a notable increase in event-free survival in the early stages of head and neck squamous cell carcinoma when using […]
Leading biopharmaceutical business Concord Biotech is situated in India and specialised in fermentation-based active medicinal components. They provide oncology APIs and immunosuppressants to more than 70 nations, including regulated markets like the U.S., Europe, and Japan. The business is one of the few fermentation-based API producers that has scaled up […]
